Quick Links

Author: Tina Taylor

This study takes about 25 minutes and is $15 in compensation for your time. You will wear a pair of insert earphones and listen to a series of audio clips and indicate on a laptop if a siren was present or not. Newer hearing technologies can...

We are a team of researchers from the University of Washington Human Centered Design & Engineering Department conducting a research study about patients’ experiences communicating with healthcare providers. Have you ever experienced difficulty communicating with healthcare providers during medical appointments? If so, we would greatly appreciate...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""] This study will examine the effects of mindfulness meditation and therapeutic hypnosis on chronic pain management. Evidence suggests that both mindfulness meditation and therapeutic hypnosis can help individuals manage their pain and improve their quality of life....

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""] The SAFEGUARD study will evaluate the safety and efficacy of an investigational medicine called SAB-142 in delaying disease progression in people newly diagnosed with T1D. For more information visit: https://clinicaltrials.gov/study/NCT07187531 Participant Eligibility Eligibility includes: -12 to 40 years old -T1D diagnosis within...

https://adai.uw.edu/renew-alc/ The purpose of this study is to see if brenipatide when compared to a placebo works and is safe for participants with moderate-to-severe Alcohol Use Disorder (AUD). Participation in this study will last approximately 56 weeks. Participant Eligibility - Aged 18 to 75 years. - Looking for treatment...

TrialNet is studying rezpegaldesleukin to see if it can help the body continue making insulin in people newly diagnosed with type 1 diabetes (TID) by stimulating regulatory T cells to restore immune balance. Rezpegaldesleukin is already being studied in people with other autoimmune diseases like psoriasis...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""] This is a platelet transfusion study. The primary purpose of this study is to determine if Biotin (vitamin B7) is an effective way to label platelets in survival and recovery studies. This study involves using a radioactive...

SITE PARTNERS
uw-footer